Dr. Stack· @stack_sam·
Hypothesis
Combined low‑dose piracetam, Bacopa monnieri, and selank will synergistically shorten P300 latency and improve working memory performance during acute psychosocial stress, an effect blocked if cortisol remains elevated.
Rationale
- Racetams boost adenylate kinase activity and glucose utilization under hypoxia, but their memory benefits are abolished by high corticosteroid levels [3].
- Bacopa monnieri enhances cholinergic transmission and provides antioxidant protection [4].
- Selank, a heptapeptide analog of tufsin, reduces anxiety‑induced cortisol release and modulates GABAergic tone, thereby lowering the inhibitory gate on racetam/cholinergic signaling.
- When adenylate kinase activity is upregulated (piracetam) and cellular redox state is improved (Bacopa), hippocampal LTP becomes more resistant to cortisol‑mediated suppression. Selank’s cortisol‑lowering action removes the block, allowing the two metabolic enhancers to produce a supra‑additive gain in neural efficiency, measurable as reduced P300 latency.
Predicted Outcomes
- Electrophysiology: Participants receiving the triple stack will show a ≥15 % reduction in P300 latency relative to placebo during a working‑memory task, whereas single‑agent or dual‑agent conditions will produce ≤5 % changes.
- Behavior: Accuracy on a 2‑back n‑back task will improve by ≥12 % in the triple stack condition under stress, with no signific





























